Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles
出版年份 2022 全文链接
标题
Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles
作者
关键词
-
出版物
Frontiers in Cell and Developmental Biology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-02-03
DOI
10.3389/fcell.2021.805336
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting pan-essential genes in cancer: challenges and opportunities
- (2021) Liang Chang et al. CANCER CELL
- Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer
- (2021) Yuyan Jiang et al. Nature Communications
- Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
- (2021) Agnese Gagliardi et al. Frontiers in Pharmacology
- Current approaches in lipid-based nanocarriers for oral drug delivery
- (2021) María Plaza-Oliver et al. Drug Delivery and Translational Research
- Ubiquitination of Nonhistone Proteins in Cancer Development and Treatment
- (2021) Xiuzhen Zhang et al. Frontiers in Oncology
- Design of liposomes as drug delivery system for therapeutic applications
- (2021) Diana Guimarães et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation
- (2021) Juan Gonzalez-Valdivieso et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cancer Selective Target Degradation by Folate-Caged PROTACs
- (2021) Jing Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeted protein degraders crowd into the clinic
- (2021) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
- (2021) Si-Min Qi et al. Frontiers in Pharmacology
- From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein Degradation
- (2021) Carlotta Cecchini et al. Frontiers in Chemistry
- Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
- (2021) Thai Thanh Hoang Thi et al. Vaccines
- Lipid Nanoparticles—From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
- (2021) Rumiana Tenchov et al. ACS Nano
- The Future of Medicinal Chemistry, PROTAC, and Undruggable Drug Targets
- (2021) Antti Poso JOURNAL OF MEDICINAL CHEMISTRY
- Unraveling the Role of Linker Design in Proteolysis Targeting Chimeras
- (2021) Troy A. Bemis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Polyester Polymeric Nanoparticles as Platforms in the Development of Novel Nanomedicines for Cancer Treatment
- (2021) Enrique Niza et al. Cancers
- Light-Controllable PROTACs for Temporospatial Control of Protein Degradation
- (2021) Jing Liu et al. Frontiers in Cell and Developmental Biology
- KRAS Inhibitors– yes but what next? Direct targeting of KRAS– vaccines, adoptive T cell therapy and beyond
- (2021) Misako Nagasaka et al. CANCER TREATMENT REVIEWS
- VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives
- (2021) Chao Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Developments of CRBN-based PROTACs as potential therapeutic agents
- (2021) Chao Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib
- (2021) Fansheng Ran et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Nanomedicine for increasing the oral bioavailability of cancer treatments
- (2021) Alessandro Parodi et al. JOURNAL OF NANOBIOTECHNOLOGY
- Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase
- (2021) Sandeep Rana et al. Cancers
- Safety and efficacy of iron supplementation after myocardial infarction in mice with moderate blood loss anaemia
- (2021) Patricia Wischmann et al. ESC Heart Failure
- Antibody–PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
- (2020) Marı́a Maneiro et al. ACS Chemical Biology
- Targeted degradation of anaplastic lymphoma kinase by gold nanoparticle-based multi-headed proteolysis targeting chimeras
- (2020) Yingming Wang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
- (2020) Sajid Khan et al. ONCOGENE
- Oral Drug Delivery with Nanoparticles into the Gastrointestinal Mucosa
- (2020) Jiao Liu et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Lysosome-targeting chimaeras for degradation of extracellular proteins
- (2020) Steven M. Banik et al. NATURE
- Understanding and Improving the Membrane Permeability of VH032-Based PROTACs
- (2020) Victoria G. Klein et al. ACS Medicinal Chemistry Letters
- Systematic Investigation of the Permeability of Androgen Receptor PROTACs
- (2020) Duncan E. Scott et al. ACS Medicinal Chemistry Letters
- Antibody-Drug Conjugates: A Promising Novel Therapy for the Treatment of Ovarian Cancer
- (2020) Aranzazu Manzano et al. Cancers
- First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivo
- (2020) Mingming Wei et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment
- (2020) Alberto Juan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Delivering the power of nanomedicine to patients today
- (2020) Matthieu Germain et al. JOURNAL OF CONTROLLED RELEASE
- Proteolysis targeting chimeras (PROTACs) in cancer therapy
- (2020) Alberto Ocaña et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PROTAC-DB: an online database of PROTACs
- (2020) Gaoqi Weng et al. NUCLEIC ACIDS RESEARCH
- Nanoformulation of BRD4-Degrading PROTAC: Improving Druggability To Target the ‘Undruggable’ MYC in Pancreatic Cancer
- (2020) Tamara Minko TRENDS IN PHARMACOLOGICAL SCIENCES
- An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy
- (2020) Alberto Juan et al. Pharmaceutics
- Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded Polymeric Antibody Conjugated Nanoparticles in Breast Cancer
- (2020) Francisco J. Cimas et al. Pharmaceutics
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
- (2019) Seyed Mohammadali Dadfar et al. ADVANCED DRUG DELIVERY REVIEWS
- The PROTAC technology in drug development
- (2019) Yutian Zou et al. CELL BIOCHEMISTRY AND FUNCTION
- Modelling dose and schedule effects of AZD2811 nanoparticles targeting aurora kinase B for treatment of diffuse large B-cell lymphoma
- (2019) Nicolas Floc'h et al. MOLECULAR CANCER THERAPEUTICS
- From poly(alkyl cyanoacrylate) to squalene as core material for the design of nanomedicines
- (2019) Simona Mura et al. JOURNAL OF DRUG TARGETING
- BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
- (2019) William Farnaby et al. Nature Chemical Biology
- Cytotoxicity of Dendrimers
- (2019) Janaszewska et al. Biomolecules
- PROTACs as Potential Therapeutic Agents for Cancer Drug Resistance
- (2019) Xiuyun Sun et al. BIOCHEMISTRY
- Light-Induced Protein Degradation with Photocaged PROTACs
- (2019) Gang Xue et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Smart cancer nanomedicine
- (2019) Roy van der Meel et al. Nature Nanotechnology
- A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
- (2019) Sajid Khan et al. NATURE MEDICINE
- Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer
- (2019) Enrique Niza et al. Nanomaterials
- Niosomes, an alternative for liposomal delivery
- (2018) Rianne Bartelds et al. PLoS One
- Abstract 5236: ARV-110: An androgen receptor PROTAC degrader for prostate cancer
- (2018) Taavi Neklesa et al. CANCER RESEARCH
- The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery
- (2018) Samuel A. Smith et al. BIOCONJUGATE CHEMISTRY
- Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles
- (2017) Fatma Mady et al. International Journal of Nanomedicine
- Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy
- (2017) Lei Zhu et al. Nanomedicine
- Targeted protein degradation by PROTACs
- (2017) Taavi K. Neklesa et al. PHARMACOLOGY & THERAPEUTICS
- Cotransporting Ion is a Trigger for Cellular Endocytosis of Transporter-Targeting Nanoparticles: A Case Study of High-Efficiency SLC22A5 (OCTN2)-Mediated Carnitine-Conjugated Nanoparticles for Oral Delivery of Therapeutic Drugs
- (2017) Longfa Kou et al. Advanced Healthcare Materials
- Systemic delivery of siRNA via targeted nanoparticles in patients with cancer: Results from a first-in-class phase I clinical trial.
- (2017) A. Ribas et al. JOURNAL OF CLINICAL ONCOLOGY
- Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study
- (2016) Minish M. Jain et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors
- (2016) D. D. Von Hoff et al. CLINICAL CANCER RESEARCH
- A phase 2 study of BIND-014 (PSMA-targeted docetaxel nanoparticle) administered to patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC).
- (2016) Karen A. Autio et al. JOURNAL OF CLINICAL ONCOLOGY
- Shape control of inorganic nanoparticles from solution
- (2016) Zhaohui Wu et al. Nanoscale
- Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras
- (2016) Honorine Lebraud et al. ACS Central Science
- Quantitative Analysis of Thiolated Ligand Exchange on Gold Nanoparticles Monitored by 1H NMR Spectroscopy
- (2015) Ashley M. Smith et al. ANALYTICAL CHEMISTRY
- Trastuzumab guided nanotheranostics: A lipid based multifunctional nanoformulation for targeted drug delivery and imaging in breast cancer therapy
- (2015) Priyambada Parhi et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Catalytic in vivo protein knockdown by small-molecule PROTACs
- (2015) Daniel P Bondeson et al. Nature Chemical Biology
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2
- (2015) Atanasio Pandiella et al. Oncotarget
- Advances and Challenges of Liposome Assisted Drug Delivery
- (2015) Lisa Sercombe et al. Frontiers in Pharmacology
- Polymeric Nanoparticle Technologies for Oral Drug Delivery
- (2014) Eric M. Pridgen et al. Clinical Gastroenterology and Hepatology
- 41 Clinical activity of BIND-014 (docetaxel nanoparticles for injectable suspension) as second-line therapy in patients (pts) with Stage III/IV non-small cell lung cancer
- (2014) R. Natale et al. EUROPEAN JOURNAL OF CANCER
- Tumour heterogeneity and the evolution of polyclonal drug resistance
- (2014) Rebecca A. Burrell et al. Molecular Oncology
- Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
- (2014) J. E. Zuckerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Orally administered liposomal formulations for colon targeted drug delivery
- (2014) Susan Hua Frontiers in Pharmacology
- Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Resistant Disease
- (2013) Kadoaki Ohashi et al. JOURNAL OF CLINICAL ONCOLOGY
- Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs
- (2013) J. Hines et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1α
- (2012) Dennis L. Buckley et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
- (2011) Laura M. Ensign et al. ADVANCED DRUG DELIVERY REVIEWS
- Acquired resistance to drugs targeting receptor tyrosine kinases
- (2011) Steven A. Rosenzweig BIOCHEMICAL PHARMACOLOGY
- Protein Knockdown Using Methyl Bestatin−Ligand Hybrid Molecules: Design and Synthesis of Inducers of Ubiquitination-Mediated Degradation of Cellular Retinoic Acid-Binding Proteins
- (2010) Yukihiro Itoh et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Impact of linker length on the activity of PROTACs
- (2010) Kedra Cyrus et al. Molecular BioSystems
- Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds
- (2010) Pilar Rivera Gil et al. PHARMACOLOGICAL RESEARCH
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- Phase II Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients with Advanced Pancreatic Cancer
- (2009) Muhammad W. Saif et al. CANCER INVESTIGATION
- Current advances in research and clinical applications of PLGA-based nanotechnology
- (2009) Jian-Ming Lü et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
- (2008) Ashley R. Schneekloth et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started